Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy ...
When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer ...
September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...
A Phase I/II clinical trial shows that a stem cell transplant that removes CD33 from donor cells using CRISPR can prevent ...
9don MSN
Leukemia stem cells cause treatments to fail, but findings open new avenues to overcome resistance
Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism ...
CHARLESTON, S.C. (WCIV) — MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment. Sophie Paczesny, M.D., Ph.D., the principal investigator for ...
A new study confirmed an elevated risk for myelodysplastic syndrome or acute myeloid leukemia (MDS/AML) after poly(ADP-ribose) polymerase (PARP) inhibitor therapy in women with ovarian cancer and ...
Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment - immunotherapy - may help change the environment where cancer cells ...
A patient details diagnosis, transplant treatment and the complex path to recovery and survivorship after leukemia. Amanda ...
Acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) are types of blood cancer. Acute lymphoblastic leukemia is a fast-growing type of blood cancer. It happens when the body makes too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results